BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23539377)

  • 41. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients.
    Adelson M; Peles E; Bodner G; Kreek MJ
    J Addict Dis; 2007; 26(1):15-26. PubMed ID: 17439864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
    Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
    Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.
    Evans E; Li L; Min J; Huang D; Urada D; Liu L; Hser YI; Nosyk B
    Addiction; 2015 Jun; 110(6):996-1005. PubMed ID: 25644938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of methadone and its role in fatalities.
    Corkery JM; Schifano F; Ghodse AH; Oyefeso A
    Hum Psychopharmacol; 2004 Dec; 19(8):565-76. PubMed ID: 15378662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methadone therapy for opioid dependence.
    Krambeer LL; von McKnelly W; Gabrielli WF; Penick EC
    Am Fam Physician; 2001 Jun; 63(12):2404-10. PubMed ID: 11430455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Weight gain among the patients in methadone maintenance program as come-back to population norm].
    Okruhlica L; Slezáková S
    Cas Lek Cesk; 2008; 147(8):426-30. PubMed ID: 18777802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of other opioids during methadone therapy: a population-based study.
    Kurdyak P; Gomes T; Yao Z; Mamdani MM; Hellings C; Fischer B; Rehm J; Bayoumi AM; Juurlink DN
    Addiction; 2012 Apr; 107(4):776-80. PubMed ID: 22050078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prescribing to drug misusers in practice--often effective, but rarely straightforward.
    Seivewright N; Iqbal MZ
    Addict Biol; 2002 Jul; 7(3):269-77. PubMed ID: 12126485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
    Chawarski MC; Zhou W; Schottenfeld RS
    Drug Alcohol Depend; 2011 Jun; 115(3):237-9. PubMed ID: 21159452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting.
    Nolan S; Hayashi K; Milloy MJ; Kerr T; Dong H; Lima VD; Lappalainen L; Montaner J; Wood E
    Drug Alcohol Depend; 2015 Nov; 156():57-61. PubMed ID: 26455554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
    Clark CB; Hendricks PS; Lane PS; Trent L; Cropsey KL
    Addict Behav; 2014 Dec; 39(12):1736-40. PubMed ID: 25117851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New formulation of methadone for opioid dependence in France: acceptability and diversion/misuse liability.
    Eiden C; Léglise Y; Bertomeu L; Clavel V; Faillie JL; Petit P; Peyrière H
    Therapie; 2013; 68(2):107-11. PubMed ID: 23773351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Problems with maintenance therapy in opiate dependence and the clinical importance of methadone].
    Wilczek H
    Cas Lek Cesk; 1998 Nov; 137(23):725-8. PubMed ID: 9990177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006.
    Nosyk B; Marsh DC; Sun H; Schechter MT; Anis AH
    J Subst Abuse Treat; 2010 Jul; 39(1):22-31. PubMed ID: 20418051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.
    Marsch LA
    Addiction; 1998 Apr; 93(4):515-32. PubMed ID: 9684390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maintenance for opioid addiction with buprenorphine and methadone: "The only thing new in the world is the history you don't know".
    Stimmel B
    J Addict Dis; 2005; 24(3):1-6. PubMed ID: 16186079
    [No Abstract]   [Full Text] [Related]  

  • 60. Eyes wide shut?--A conceptual and empirical critique of methadone maintenance treatment.
    Fischer B; Rehm J; Kim G; Kirst M
    Eur Addict Res; 2005; 11(1):1-9; discussion 10-4. PubMed ID: 15608466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.